To determine the cellular origin of IL21 in human tumor tissues, we analyzed public scRNA-seq data of 8,530 T cells from 12 patients with colon cancer, 9,055 T cells from 14 patients with non–small cell lung cancer, and 5,063 T cells from 6 patients with liver cancer (9–11). This evidence concerns the gene IL21 and neoplasm.